Akili to Participate in the Cowen 43rd Annual Health Care Conference
02 February 2023 - 11:00PM
Business Wire
Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company,
will participate in the Cowen 43rd Annual Health Care Conference in
Boston next month.
On March 8, Akili sessions are scheduled for the following
times:
- 8am: Scott Kollins, Akili Chief Medical Officer, will represent
the company on a panel discussion about prescription digital
therapeutics (PDTs) and how PDTs can aid in overall care and
outcomes.
- 9:50 am: Fireside Chat with Eddie Martucci, Akili Co-Founder
and Chief Executive Officer & Matt Franklin, President and
Chief Operating Officer
Company leaders will also meet with investors throughout the day
on March 8.
About Akili
Akili is pioneering the development of cognitive treatments
through game-changing technologies. Akili’s approach of leveraging
technologies designed to directly target the brain establishes a
new category of medicine – medicine that is validated through
clinical trials like a drug or medical device but experienced like
entertainment. Akili’s platform is powered by proprietary
therapeutic engines designed to target cognitive impairment at its
source in the brain, informed by decades of research and validated
through rigorous clinical programs. Driven by Akili’s belief that
effective medicine can also be fun and engaging, Akili’s products
are delivered through captivating action video game experiences.
For more information, please visit www.akiliinteractive.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230202005499/en/
Investor Contact: Santosh Shanbhag Chief Financial
Officer sshanbhag@akiliinteractive.com
Media Contact: Julie DiCarlo SVP, Communications
jdicarlo@akiliinteractive.com
Akili (NASDAQ:AKLI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akili (NASDAQ:AKLI)
Historical Stock Chart
From Apr 2023 to Apr 2024